Philosophical Transactions: Biological Sciences, Vol. 374, No. 1773, Silent cancer agents: multi-disciplinary modelling of human DNA oncoviruses (27 May 2019), pp. 1-11 (11 pages) Most human ...

Human papillomavirus–associated oropharynx cancer (HPVA-OPC) is rapidly increasing in incidence and has unique epidemiologic, molecular, and biologic characteristics. Despite being recognized as ...

Oropharynx cancer (OPC) constitutes the most common location for squamous-cell head and neck cancer, and most OPC is caused by the human papilloma virus (HPV). Early-stage (American Joint Committee on ...

WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new study. These ...

Please provide your email address to receive an email when new articles are posted on . Zhang and colleagues obtained data from the Surveillance, Epidemiology, and End Results program from 69,562 ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancers — tumors of the back of the mouth and throat — is rising. If caught early, most of these cancers have a high survival rate, ...

The head and neck cancer community has been working to de-escalate treatment for human papillomavirus (HPV)–associated oropharynx squamous cell carcinomas for several years in hopes of preserving ...

Head and neck cancers arising from the upper aerodigestive tract are the sixth leading cause of cancer-related mortality, with over 550,000 new cases per year. Though it continues to be prevalent, the ...

Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health ...

Plasma Micro-RNA 371 Expression in Early-Stage Germ Cell Tumors: Are We Ready to Move Toward Biology-Based Decision Making? The following represents disclosure information provided by authors of this ...